These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26130113)

  • 21. Ceramide in lipid emulsions used in parenteral nutrition: an innocent bystander?
    Groener JE; Serlie MJ; Poppema A; Mirzaian M; Aerts JM
    JPEN J Parenter Enteral Nutr; 2011 Mar; 35(2):270-1. PubMed ID: 21378257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
    Rochling FA
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The intestinal microbiome and paediatric liver disease.
    Leung DH; Yimlamai D
    Lancet Gastroenterol Hepatol; 2017 Jun; 2(6):446-455. PubMed ID: 28497760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
    Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
    Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation.
    Cowles RA; Ventura KA; Martinez M; Lobritto SJ; Harren PA; Brodlie S; Carroll J; Jan DM
    J Pediatr Surg; 2010 Jan; 45(1):84-7; discussion 87-8. PubMed ID: 20105585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Gut Microbiome in Patients with Intestinal Failure: Current Evidence and Implications for Clinical Practice.
    Neelis E; de Koning B; Rings E; Wijnen R; Nichols B; Hulst J; Gerasimidis K
    JPEN J Parenter Enteral Nutr; 2019 Feb; 43(2):194-205. PubMed ID: 30070709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of fish oil lipid emulsion in the treatment of intestinal failure associated liver disease (IFALD).
    Chang MI; Puder M; Gura KM
    Nutrients; 2012 Nov; 4(12):1828-50. PubMed ID: 23363993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Composite Lipid Emulsion for the Infant at Risk of Intestinal Failure-associated Liver Disease: The Canadian Perspective.
    Silverman JA; Turner JM; Wales PW
    J Pediatr Gastroenterol Nutr; 2020 Sep; 71(3):283-287. PubMed ID: 32459744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
    Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Parenteral Lipid Emulsion Components on Cholestatic Liver Disease in Neonates.
    Guthrie G; Burrin D
    Nutrients; 2021 Feb; 13(2):. PubMed ID: 33557154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease.
    Cober MP; Killu G; Brattain A; Welch KB; Kunisaki SM; Teitelbaum DH
    J Pediatr; 2012 Mar; 160(3):421-7. PubMed ID: 21982303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Index Use of Smoflipid in a Tertiary Intestinal Rehabilitation and Transplantation Program.
    Lam K; Schiano T; Fiel MI; Iyer K
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(1_suppl):20S-23S. PubMed ID: 29161210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proinflammatory mediators in lipid emulsions and parenteral nutrition-associated liver disease: Review of leading factors.
    Driscoll DF
    JPEN J Parenter Enteral Nutr; 2023 Aug; 47(6):710-717. PubMed ID: 37070817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal Failure-Associated Liver Disease in Neonates.
    Fundora J; Aucott SW
    Neoreviews; 2020 Sep; 21(9):e591-e599. PubMed ID: 32873652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic complications of parenteral nutrition.
    Bower RH
    Semin Liver Dis; 1983 Aug; 3(3):216-24. PubMed ID: 6414087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supplemental Parenteral Vitamin E Into Conventional Soybean Lipid Emulsion Does Not Prevent Parenteral Nutrition-Associated Liver Disease in Full-Term Neonatal Piglets.
    Muto M; Lim D; Soukvilay A; Field C; Wizzard PR; Goruk S; Ball RO; Pencharz PB; Mi S; Curtis J; Wales PW; Turner JM
    JPEN J Parenter Enteral Nutr; 2017 May; 41(4):575-582. PubMed ID: 26471989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal failure-associated liver disease: a position paper of the ESPGHAN Working Group of Intestinal Failure and Intestinal Transplantation.
    Lacaille F; Gupte G; Colomb V; D'Antiga L; Hartman C; Hojsak I; Kolacek S; Puntis J; Shamir R;
    J Pediatr Gastroenterol Nutr; 2015 Feb; 60(2):272-83. PubMed ID: 25272324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel lipid-based approaches to pediatric intestinal failure-associated liver disease.
    Diamond IR; Pencharz PB; Feldman BM; Ling SC; Moore AM; Wales PW
    Arch Pediatr Adolesc Med; 2012 May; 166(5):473-8. PubMed ID: 22566549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency.
    Gunnar R; Lumia M; Pakarinen M; Merras-Salmio L
    JPEN J Parenter Enteral Nutr; 2018 Sep; 42(7):1203-1210. PubMed ID: 29701873
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipids and liver dysfunction in patients receiving parenteral nutrition.
    Gabe SM
    Curr Opin Clin Nutr Metab Care; 2013 Mar; 16(2):150-5. PubMed ID: 23340009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.